Piotr Stefan Sobieszczyk, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 6 | 2018 | 2591 | 0.940 |
Why?
|
| Superior Vena Cava Syndrome | 3 | 2020 | 56 | 0.910 |
Why?
|
| Brugada Syndrome | 2 | 2018 | 98 | 0.690 |
Why?
|
| Aortic Valve Stenosis | 7 | 2022 | 2032 | 0.660 |
Why?
|
| Aortic Valve | 7 | 2022 | 1968 | 0.640 |
Why?
|
| Vena Cava Filters | 3 | 2018 | 270 | 0.630 |
Why?
|
| Intermittent Claudication | 3 | 2015 | 305 | 0.570 |
Why?
|
| Thrombolytic Therapy | 5 | 2016 | 2058 | 0.560 |
Why?
|
| Coronary Restenosis | 2 | 2017 | 396 | 0.550 |
Why?
|
| Fibrinolytic Agents | 5 | 2015 | 2082 | 0.550 |
Why?
|
| Heart Valve Prosthesis Implantation | 7 | 2021 | 1569 | 0.550 |
Why?
|
| Popliteal Artery | 2 | 2016 | 313 | 0.540 |
Why?
|
| Peripheral Arterial Disease | 5 | 2023 | 1299 | 0.530 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2015 | 86 | 0.460 |
Why?
|
| Defibrillators, Implantable | 4 | 2018 | 1498 | 0.450 |
Why?
|
| Drug-Eluting Stents | 2 | 2017 | 681 | 0.430 |
Why?
|
| Angioplasty, Balloon | 4 | 2020 | 592 | 0.410 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2016 | 1166 | 0.410 |
Why?
|
| Femoral Artery | 6 | 2023 | 829 | 0.400 |
Why?
|
| Brachytherapy | 2 | 2017 | 1227 | 0.390 |
Why?
|
| Tachycardia, Ventricular | 7 | 2018 | 1309 | 0.380 |
Why?
|
| Endovascular Procedures | 4 | 2023 | 2258 | 0.380 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 143 | 0.370 |
Why?
|
| Heart Valve Prosthesis | 5 | 2021 | 1468 | 0.360 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2010 | 15 | 0.360 |
Why?
|
| Shock, Cardiogenic | 2 | 2015 | 711 | 0.360 |
Why?
|
| Vena Cava, Superior | 3 | 2020 | 197 | 0.350 |
Why?
|
| Anticoagulants | 5 | 2018 | 4840 | 0.340 |
Why?
|
| Ventricular Function, Right | 1 | 2012 | 629 | 0.310 |
Why?
|
| Ethanol | 5 | 2015 | 1334 | 0.300 |
Why?
|
| Exercise Therapy | 1 | 2015 | 941 | 0.290 |
Why?
|
| Thrombosis | 3 | 2018 | 2956 | 0.290 |
Why?
|
| Ultrasonography, Interventional | 2 | 2017 | 1519 | 0.290 |
Why?
|
| Aftercare | 1 | 2013 | 921 | 0.280 |
Why?
|
| Catheter Ablation | 7 | 2018 | 2775 | 0.270 |
Why?
|
| Thrombectomy | 2 | 2016 | 706 | 0.260 |
Why?
|
| Vasodilation | 1 | 2010 | 968 | 0.260 |
Why?
|
| Electrocardiography | 3 | 2018 | 6410 | 0.260 |
Why?
|
| Angioplasty | 3 | 2015 | 357 | 0.260 |
Why?
|
| Constriction, Pathologic | 5 | 2019 | 1103 | 0.250 |
Why?
|
| Heart-Assist Devices | 2 | 2015 | 1292 | 0.250 |
Why?
|
| Carotid Artery Diseases | 2 | 2015 | 879 | 0.250 |
Why?
|
| Catheterization | 2 | 2010 | 1431 | 0.250 |
Why?
|
| Stents | 7 | 2016 | 3204 | 0.250 |
Why?
|
| Device Removal | 4 | 2020 | 641 | 0.230 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 1494 | 0.220 |
Why?
|
| Bioprosthesis | 2 | 2018 | 592 | 0.220 |
Why?
|
| Treatment Outcome | 26 | 2023 | 65409 | 0.220 |
Why?
|
| Mitral Valve | 4 | 2021 | 1473 | 0.200 |
Why?
|
| Carotid Arteries | 1 | 2006 | 943 | 0.200 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2014 | 2768 | 0.180 |
Why?
|
| Dyspnea | 3 | 2018 | 1352 | 0.170 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 3734 | 0.170 |
Why?
|
| Combined Modality Therapy | 4 | 2018 | 8559 | 0.160 |
Why?
|
| Prosthesis Failure | 2 | 2018 | 1208 | 0.160 |
Why?
|
| Vascular Patency | 2 | 2013 | 916 | 0.160 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2021 | 262 | 0.160 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2018 | 511 | 0.160 |
Why?
|
| Brachiocephalic Veins | 1 | 2018 | 21 | 0.160 |
Why?
|
| Vena Cava, Inferior | 2 | 2024 | 463 | 0.150 |
Why?
|
| Venous Thromboembolism | 2 | 2024 | 1884 | 0.150 |
Why?
|
| Cryosurgery | 2 | 2015 | 477 | 0.140 |
Why?
|
| Cough | 2 | 2018 | 598 | 0.140 |
Why?
|
| Rehabilitation Centers | 1 | 2019 | 250 | 0.140 |
Why?
|
| Heart Aneurysm | 1 | 2017 | 114 | 0.140 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2017 | 142 | 0.130 |
Why?
|
| Humans | 55 | 2024 | 768451 | 0.130 |
Why?
|
| Electrodes, Implanted | 1 | 2020 | 841 | 0.130 |
Why?
|
| Bundle-Branch Block | 1 | 2018 | 278 | 0.130 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2011 | 751 | 0.130 |
Why?
|
| Ankle Brachial Index | 2 | 2013 | 163 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2013 | 198 | 0.120 |
Why?
|
| Credentialing | 1 | 2015 | 114 | 0.120 |
Why?
|
| Endarterectomy, Carotid | 2 | 2014 | 558 | 0.120 |
Why?
|
| Hemodynamics | 4 | 2018 | 4202 | 0.120 |
Why?
|
| Adenosine Monophosphate | 1 | 2016 | 233 | 0.120 |
Why?
|
| Risk Assessment | 9 | 2020 | 24311 | 0.120 |
Why?
|
| Time Factors | 10 | 2021 | 40271 | 0.120 |
Why?
|
| Female | 34 | 2022 | 396943 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2017 | 538 | 0.110 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2015 | 278 | 0.110 |
Why?
|
| Echocardiography | 3 | 2017 | 5043 | 0.110 |
Why?
|
| Aged | 24 | 2021 | 171520 | 0.110 |
Why?
|
| Male | 33 | 2023 | 364781 | 0.110 |
Why?
|
| Heart Failure | 3 | 2017 | 11857 | 0.110 |
Why?
|
| Recovery of Function | 4 | 2018 | 2994 | 0.100 |
Why?
|
| Secondary Prevention | 2 | 2013 | 1479 | 0.100 |
Why?
|
| Home Care Services | 1 | 2019 | 655 | 0.100 |
Why?
|
| Arteriovenous Fistula | 1 | 2015 | 321 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2002 | 2485 | 0.100 |
Why?
|
| Risk Factors | 12 | 2023 | 74915 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 10358 | 0.100 |
Why?
|
| Forecasting | 1 | 2020 | 2950 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2016 | 1724 | 0.090 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2015 | 350 | 0.090 |
Why?
|
| Leg | 2 | 2016 | 1089 | 0.090 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2010 | 18 | 0.090 |
Why?
|
| Pericardium | 1 | 2015 | 679 | 0.090 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2010 | 64 | 0.090 |
Why?
|
| Cortisone | 1 | 2010 | 90 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 1033 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2018 | 1568 | 0.080 |
Why?
|
| Drug Approval | 1 | 2016 | 817 | 0.080 |
Why?
|
| Recurrence | 4 | 2016 | 8510 | 0.080 |
Why?
|
| Ischemia | 2 | 2023 | 1900 | 0.080 |
Why?
|
| Prosthesis Design | 4 | 2018 | 2126 | 0.080 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2012 | 489 | 0.080 |
Why?
|
| Embolectomy | 1 | 2010 | 130 | 0.080 |
Why?
|
| Body Surface Potential Mapping | 1 | 2010 | 228 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3434 | 0.080 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 220 | 0.080 |
Why?
|
| Catheters | 1 | 2011 | 427 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2019 | 3471 | 0.080 |
Why?
|
| Survival Rate | 3 | 2018 | 12875 | 0.070 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 1414 | 0.070 |
Why?
|
| Tetrazoles | 1 | 2013 | 922 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 1 | 2011 | 438 | 0.070 |
Why?
|
| Physical Examination | 1 | 2013 | 1262 | 0.070 |
Why?
|
| Aspirin | 2 | 2013 | 3139 | 0.070 |
Why?
|
| Embolism | 1 | 2010 | 401 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1502 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2013 | 1481 | 0.070 |
Why?
|
| Radial Artery | 1 | 2008 | 188 | 0.070 |
Why?
|
| Boston | 4 | 2023 | 9361 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 2145 | 0.070 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 864 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 1318 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 491 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 2056 | 0.060 |
Why?
|
| Limb Salvage | 2 | 2023 | 489 | 0.060 |
Why?
|
| Equipment Design | 2 | 2011 | 3530 | 0.060 |
Why?
|
| Lower Extremity | 2 | 2023 | 1214 | 0.060 |
Why?
|
| Stroke Volume | 2 | 2017 | 5620 | 0.060 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2010 | 614 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 3941 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2969 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 755 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 15965 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2103 | 0.060 |
Why?
|
| Hospital Mortality | 3 | 2019 | 5371 | 0.060 |
Why?
|
| Adult | 11 | 2021 | 223542 | 0.060 |
Why?
|
| Middle Aged | 16 | 2021 | 223418 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1949 | 0.050 |
Why?
|
| Angiography | 1 | 2008 | 1598 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 8051 | 0.050 |
Why?
|
| Disease Management | 1 | 2013 | 2533 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 13324 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2010 | 1836 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 2028 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 59680 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20762 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 1333 | 0.050 |
Why?
|
| Retrospective Studies | 8 | 2020 | 81834 | 0.040 |
Why?
|
| Injections, Intravenous | 2 | 2016 | 1379 | 0.040 |
Why?
|
| Marital Status | 1 | 2022 | 426 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 11515 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6551 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2011 | 2780 | 0.040 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 578 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 1142 | 0.040 |
Why?
|
| Cerebral Angiography | 2 | 2015 | 1282 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10845 | 0.040 |
Why?
|
| Radiography | 1 | 2010 | 6995 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 30028 | 0.040 |
Why?
|
| Stroke | 2 | 2014 | 9791 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13655 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 4425 | 0.040 |
Why?
|
| Ticlopidine | 1 | 2002 | 730 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39430 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2015 | 2656 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 12561 | 0.030 |
Why?
|
| Livedo Reticularis | 1 | 2016 | 5 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2009 | 2816 | 0.030 |
Why?
|
| Tachycardia, Sinus | 1 | 2016 | 43 | 0.030 |
Why?
|
| Stockings, Compression | 1 | 2016 | 36 | 0.030 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 125 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12450 | 0.030 |
Why?
|
| Aortography | 1 | 2018 | 422 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 353 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2016 | 513 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 1943 | 0.030 |
Why?
|
| Aerospace Medicine | 1 | 2016 | 95 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3438 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 2016 | 293 | 0.030 |
Why?
|
| Phlebography | 1 | 2016 | 326 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2011 | 1095 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 5336 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2010 | 8538 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6521 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2016 | 284 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 463 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2018 | 881 | 0.030 |
Why?
|
| Benchmarking | 1 | 2020 | 1058 | 0.030 |
Why?
|
| Pacemaker, Artificial | 1 | 2018 | 828 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2020 | 4841 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15460 | 0.020 |
Why?
|
| Coronary Angiography | 2 | 2017 | 4526 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2016 | 409 | 0.020 |
Why?
|
| Edema | 1 | 2016 | 766 | 0.020 |
Why?
|
| Acute Disease | 1 | 2002 | 7246 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5162 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3253 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2022 | 6537 | 0.020 |
Why?
|
| Massachusetts | 2 | 2017 | 8908 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 2011 | 178 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2015 | 775 | 0.020 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 1990 | 24 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 1127 | 0.020 |
Why?
|
| Suction | 1 | 2011 | 268 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1813 | 0.020 |
Why?
|
| Heart Block | 1 | 2011 | 390 | 0.020 |
Why?
|
| Emergencies | 1 | 2016 | 1222 | 0.020 |
Why?
|
| Retreatment | 1 | 2011 | 601 | 0.020 |
Why?
|
| Hemoptysis | 1 | 2010 | 152 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 806 | 0.020 |
Why?
|
| Heparin | 1 | 2016 | 1636 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1669 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15880 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2016 | 989 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 1120 | 0.020 |
Why?
|
| United States | 4 | 2020 | 73121 | 0.020 |
Why?
|
| Wrist | 1 | 2008 | 232 | 0.020 |
Why?
|
| Hypertension | 1 | 2006 | 8611 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2020 | 41797 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 3207 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 681 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3122 | 0.020 |
Why?
|
| Heart Atria | 1 | 2011 | 1361 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10647 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 1266 | 0.010 |
Why?
|
| Reoperation | 1 | 2015 | 4342 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2020 | 8081 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2017 | 2958 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 60045 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2015 | 3955 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 2411 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18388 | 0.010 |
Why?
|
| Hand | 1 | 2008 | 907 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 6657 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 54914 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6242 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10125 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 1509 | 0.010 |
Why?
|
| Curriculum | 1 | 2015 | 3778 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3708 | 0.010 |
Why?
|
| Aorta | 1 | 2009 | 2046 | 0.010 |
Why?
|
| Medicare | 1 | 2020 | 6881 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2008 | 1189 | 0.010 |
Why?
|
| Patient Selection | 1 | 2011 | 4266 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 2226 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9687 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5308 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 30179 | 0.010 |
Why?
|
| Inpatients | 1 | 2008 | 2561 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1990 | 6610 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7471 | 0.010 |
Why?
|
| Obesity | 1 | 2014 | 13065 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 169418 | 0.010 |
Why?
|
| Asparagine | 1 | 1990 | 120 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12242 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1734 | 0.000 |
Why?
|
| Aspartic Acid | 1 | 1990 | 577 | 0.000 |
Why?
|
| Base Sequence | 1 | 1990 | 12428 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 13452 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 17647 | 0.000 |
Why?
|
| DNA | 1 | 1990 | 7213 | 0.000 |
Why?
|
| Phenotype | 1 | 1990 | 16712 | 0.000 |
Why?
|
| Mutation | 1 | 1990 | 30243 | 0.000 |
Why?
|